Floatz logo

Therapeutic Asset Ratings

766 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
18f-psma
Metastasis From Malignant Tumor Of Colon
Primo Biotechnology Co., LtdP1CC (44)
[68ga]ga-oncocaix
Nonpapillary Renal Cell Carcinoma
Philogen S.p.A.P1CC (44)
68ga-lnc1007
Healthy Volunteers
Yantai LNC Biotechnology Singapore PTE. LTD.P1CC (44)
68ga-nota-sna002
Neoplasm
SmartNuclide BiopharmaP1CC (44)
111in-etn029
Gastroenteropancreatic Neuroendocrine Carcinoma
Novartis PharmaceuticalsP1CC (43)
111in-etn029
Pulmonary Large Cell Neuroendocrine Carcinoma
Novartis PharmaceuticalsP1CC (43)
111in-etn029
Prostate Neuroendocrine Neoplasm
Novartis PharmaceuticalsP1CC (43)
[111in]-fpi-2058
Prostate Neuroendocrine Neoplasm
3B Pharmaceuticals GmbHP1CC (43)
[111in]-fpi-2058
NTSR1 Expressing Solid Tumours
3B Pharmaceuticals GmbHP1CC (43)
[111in]-fpi-2107
Non-Small Cell Lung Carcinoma
AstraZenecaP1CC (43)
[111in]-fpi-2107
Colorectal Carcinoma
AstraZenecaP1CC (43)
111in-xyimsr-01
Renal Cell Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1CC (43)
11c-bms-986196
Multiple Sclerosis
Bristol-Myers SquibbP1CC (43)
131i-ipa
Neoplasm
Telix Pharmaceuticals (Innovations) Pty LimitedP1CC (43)
161tb-psma-i&t
Castration-Resistant Prostate Carcinoma
National Taiwan University HospitalP1CC (43)
177lu-ab-3prgd2 radioligand therapy
Refractory Malignant Neoplasm
The First Affiliated Hospital of Xiamen UniversityP1CC (43)
177lu-dfc413
Breast Carcinoma
Novartis PharmaceuticalsP1CC (43)
177lu-dtpa-sc16.56
Prostate Neuroendocrine Neoplasm
Memorial Sloan Kettering Cancer CenterP1CC (43)
177lu-dtpa-sc16.56
Lung Neuroendocrine Neoplasm
Memorial Sloan Kettering Cancer CenterP1CC (43)
[177lu]lu-aby-271
HER2 Positive Breast Carcinoma
AffibodyP1CC (43)
[177lu]lu-nns309
Breast Carcinoma
Novartis PharmaceuticalsP1CC (43)
[177lu]lu-oncofap-23
FAP
Philogen S.p.A.P1CC (43)
[177lu]lu-psma-xt
Prostate Cancer
Jinming ZhangP1CC (43)
177lu-nrt6020
Neoplasm
Chengdu New Radiomedicine Technology Co. LTD.P1CC (43)
177lu-psma
Castration-Resistant Prostate Carcinoma
Peter MacCallum Cancer Centre, AustraliaP1CC (43)
Showing 226 to 250 of 766 assets
PreviousPage 10 of 31Next